For years, topical corticosteroids have been a frontline treatment for various inflammatory skin conditions like eczema and psoriasis. Their primary advantage lies in delivering medication directly to the affected area, minimizing the systemic exposure associated with oral steroids. However, the assumption that topical application eliminates all systemic risk is a misconception. The skin, as the body's largest organ, is not an impenetrable barrier, and systemic absorption of these medications is a well-documented phenomenon. The degree to which a topical steroid acts systemically depends on multiple factors, and understanding these is essential for both patients and healthcare providers.
Understanding Systemic Absorption
Pharmacology classifies medications based on their route of administration, and topical drugs are typically understood to have localized effects. However, absorption into the systemic circulation is always possible and is influenced by the drug's properties and the condition of the skin. Once absorbed, the corticosteroid can circulate in the bloodstream and exert effects on internal organs, particularly the hypothalamic-pituitary-adrenal (HPA) axis.
Factors Influencing Systemic Absorption
The amount of a topical steroid that enters the bloodstream is not static and is determined by several critical factors:
- Potency of the steroid: Higher-potency corticosteroids, such as clobetasol, are more readily absorbed and carry a greater risk of systemic effects than lower-potency options like hydrocortisone.
- Area of application: Applying steroids over a large body surface area, such as in widespread eczema or psoriasis, dramatically increases the total amount of drug absorbed. Pediatric patients are particularly vulnerable due to a higher skin surface area-to-body weight ratio.
- Duration of treatment: Prolonged or chronic use, especially with potent steroids, increases the total dose absorbed over time, raising the risk of systemic side effects.
- Occlusion: Covering the treated area with an occlusive dressing (e.g., plastic wrap or a diaper) significantly enhances absorption by increasing skin hydration and temperature. This practice can increase absorption by up to 10 times.
- Skin barrier condition: Damaged or inflamed skin, a characteristic of many dermatological conditions, has an impaired barrier function. This allows for enhanced percutaneous absorption compared to healthy, intact skin.
- Anatomical site: The skin's thickness varies across the body. Absorption is higher in areas with thinner skin, such as the face, eyelids, and genitals, and lower on thick skin like the palms and soles.
Local vs. Systemic Side Effects
Using topical steroids can result in both localized and systemic adverse effects. The table below provides a comparison of these two categories, highlighting the differences in their manifestation and severity.
Feature | Local Side Effects | Systemic Side Effects |
---|---|---|
Mechanism | Occur directly at the application site due to local tissue effects. | Result from the drug's absorption into the bloodstream, affecting internal systems. |
Onset | Can appear relatively quickly with prolonged or high-potency use. | Generally develop with long-term, high-dose, or large-area application. |
Examples | Skin atrophy (thinning), striae (stretch marks), telangiectasias (spider veins), rosacea, and perioral dermatitis. | HPA axis suppression, iatrogenic Cushing's syndrome, growth retardation in children, hyperglycemia, and ocular issues like glaucoma. |
Prevalence | More common, especially with improper or extended use. | Rare when topical steroids are used appropriately, but risk increases with misuse. |
The Risks of Systemic Absorption
The most significant systemic risk associated with topical steroids is the suppression of the HPA axis. The body's adrenal glands naturally produce cortisol. When steroids are absorbed systemically, the body receives a signal to reduce its own cortisol production. If the external steroid is abruptly discontinued, the adrenal glands may not be able to resume sufficient cortisol production, leading to adrenal insufficiency. This can cause symptoms like fatigue, weakness, low blood pressure, and appetite loss.
Another rare but serious risk is the development of iatrogenic Cushing's syndrome, characterized by a puffy face, central obesity, and striae. This condition occurs from excessive, prolonged systemic exposure. In children, systemic absorption is a particular concern as it can lead to growth retardation, a side effect monitored carefully by pediatricians.
Minimizing Systemic Effects and Using Topical Steroids Safely
To mitigate the risk of systemic absorption and its associated side effects, patients must follow their healthcare provider's instructions carefully. The following practices are recommended for the safe and effective use of topical steroids:
- Use the lowest effective potency: Start with the mildest steroid that will control the skin condition. Potent steroids should be reserved for more severe cases and shorter durations.
- Limit treatment duration: Acute flares should be treated for the shortest time possible, typically a few weeks. For long-term management of chronic conditions, intermittent therapy (e.g., using it on weekends only) can reduce cumulative exposure.
- Avoid large application areas: Do not use potent steroids over extensive body surface areas. If a large area requires treatment, a lower-potency steroid is often a safer choice.
- Be cautious with occlusion: Avoid occlusive dressings unless specifically instructed by a doctor, especially with potent steroids. Never use occlusive dressings on infants without medical supervision.
- Avoid sensitive areas: Exercise extreme caution when applying steroids to the face, groin, and underarms, as these areas have higher absorption rates. Always use the lowest potency possible for these sensitive sites.
- Monitor pediatric use: Children, especially infants, are at a higher risk of systemic absorption. Treatment should be closely monitored by a healthcare professional.
Conclusion
In summary, while topical steroids are designed for local effects, the answer to the question are topical steroids considered systemic is a qualified 'yes.' Though the risk of systemic side effects is rare with appropriate use, it is a significant consideration, particularly with prolonged use, high potency, large application areas, or compromised skin. Patients must use these medications as prescribed and be aware of the factors that can increase absorption. By following recommended safety protocols, the therapeutic benefits of topical steroids can be maximized while minimizing the risk of adverse outcomes, ensuring safe and effective treatment for inflammatory skin diseases. For additional information on side effects, consulting authoritative sources like the National Eczema Society is recommended.